Retina Vitreous Surgeons of CNY, PC

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME	diabetic macular edema	Active, not recruiting	Phase 3	2026-10-02	NCT07449923
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration	Neovascular Age-related Macular Degeneration; nAMD	Recruiting	Phase 3	2026-09-29	NCT07614776
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD	Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder	Recruiting	Phase 2	2026-09-10	NCT06659445
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56	wet macular degeneration	Active, not recruiting	Phase 3	2026-09-03	NCT06683742
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56	wet macular degeneration	Active, not recruiting	Phase 3	2026-09-03	NCT06668064
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration	Neovascular Age-related Macular Degeneration	Active, not recruiting	Phase 3	2025-06-17	NCT06495918

Clinical trials